In CRC, ST6Gal1 expression is higher in tumor compared to normal tissue and interestingly, lower expression is observed in metastatic (stage III and IV) tumors compared to the non-metastatic ones (stage I and II) (Zhang et al., 2017). This evidence concerns the gene ST6GAL1 and colorectal carcinoma.